Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Astec LifeSciences Limited has informed the Exchange pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') that the Company will be participating in Kotak Institutional Equities (KIE) Chemical Forum 2022 scheduled to be held tomorrow, i.e., on Wednesday, 7th December, 2022 at Mumbai. We request you to kindly take the above information on your record.
06-12-2022
Bigul

ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

 This is to inform you that the Nomination and Remuneration Committee of the Board of Directors of the Company has approved allotment of 1,105 (One Thousand One Hundred and Five) Equity Shares of Face Value of Rs.10/- (Rupees Ten Only) each, as fully paid-up, to an employee of the Company on 6th December, 2022, upon exercise of 1,105 (One Thousand One Hundred and Five) Options granted to him, at an Exercise Price of Rs.10/- (Rupees Ten Only) per Equity Share, under the Company's Employees Stock Option Plan, 2012 (ESOP 2012). Please take the same on your records.
06-12-2022
Bigul

ASTEC LIFESCIENCES LIMITED - 533138 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the format specified under SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated 22nd November, 2021, please find enclosed herewith, the disclosure of Related Party Transactions for the Half Year ended 30th September, 2022. The above information is also being uploaded on the Company's website, viz., www.astecls.com We request you to take the same on your records.
11-11-2022
Bigul

ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 Please find enclosed herewith transcript of Conference call of Astec LifeSciences Limited with the Investors and Analysts held on Monday, October 31, 2022. This aforementioned information is also made available on the website of the Company i.e., www.astecls.com Kindly take note of the above.
07-11-2022
Bigul

ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Please find enclosed herewith transcript of Conference call of Astec LifeSciences Limited with the Investors and Analysts held on Monday, October 31, 2022. This aforementioned information is also made available on the website of the Company i.e., www.astecls.com
07-11-2022
Bigul

Q2FY23 Quarterly Result Announced for Astec Lifesciences Ltd.

 Agrochemicals company Astec Lifesciences announced Q2FY23 results: Q2FY23: Q2FY23 consolidated total income increased by 96.9% YoY Q2FY23 consolidated EBITDA grew by 69.5% YoY, EBITDA margin stood at 18.3% Q2FY23 Profit after tax grew by 101.8% YoY H1FY23: H1FY23 consolidated total income increased by 67.7% YoY H1FY23 consolidated EBITDA grew by 37.9% YoY, EBITDA margin stood at 16.7% H1FY23 Profit after tax grew by 34.7% YoY Commenting on the performance, Mr. N B Godrej, Chairman, Astec LifeSciences Limited, said: "Astec continued to deliver strong financial performance with 2.0x YoY growth in total income and PAT in Q2FY23. The robust growth, albeit on a low base, was driven by higher volumes as well as price realisations coupled with favorable product mix." Result PDF
02-11-2022
Bigul

ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Please note that the Audio Recording of Conference call of Astec LifeSciences Limited with the Investors and Analysts held today i.e. on Monday, October 31, 2022, is available / accessible at the website of the Company. Kindly take the same on your records.
31-10-2022
Bigul

ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 read with Schedule III and Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of the newspaper publication of the Unaudited Financial Results for the Quarter and Half Year ended 30th September, 2022, published by the Company today, i.e., on Saturday, 29th October, 2022, in Business Standard (in English language) and Mumbai Lakshadeep (in Marathi language). The newspaper advertisements may also be accessed on the website of the Company, viz., www.astecls.com. Kindly take note of the above.
29-10-2022
Bigul

ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Astec LifeSciences Limited has informed the Exchange about the Board of Directors of the Company, at its Meeting held on Friday, 28th October, 2022, has approved the Unaudited Financial Results (both Standalone and Consolidated) as per Indian Accounting Standards (IND AS) for the Quarter and Half Year ended 30th September, 2022. We enclose a copy of the Press Release and the same is being placed on the website of the Company, viz., www.astecls.com. Please take the above information on your records.
28-10-2022
Bigul

ASTEC LIFESCIENCES LIMITED - 533138 - APPOINTMENT OF MR. MADHUR GUNDECHA AS THE 'CHIEF FINANCIAL OFFICER' OF THE COMPANY:

 The Board of Directors of the Company, based on the recommendation of the Nomination and Remuneration Committee, has appointed Mr. Madhur Gundecha as the 'Chief Financial Officer' of the Company with effect from 28th October, 2022.
28-10-2022
Next Page
Close

Let's Open Free Demat Account